Efficacy and Safety of Peginterferon Alfa‐2a (40KD) in Children With Chronic Hepatitis B: The PEG‐B‐ACTIVE Study-Reference-Cited by-同舟云学术

Efficacy and Safety of Peginterferon Alfa‐2a (40KD) in Children With Chronic Hepatitis B: The PEG‐B‐ACTIVE Study

Published:2018-10-08 Issue:5 Volume:68 Page:1681-1694
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Wirth Stefan¹,Zhang Hongfei²,Hardikar Winita³,Schwarz Kathleen B.⁴,Sokal Etienne⁵,Yang Weibo⁶,Fan Huimin⁷,Morozov Vyacheslav⁸,Mao Qing⁹,Deng Hong¹⁰,Huang Yang¹¹,Yang Lei¹¹,Frey Nicolas¹²,Nasmyth‐Miller Clare¹³,Pavlovic Vedran¹³,Wat Cynthia¹³

Affiliation:

1. Department of Pediatrics, Helios Medical Center WuppertalWitten‐Herdecke University Germany

2. Beijing 302 Hospital Beijing China

3. The Royal Children’s Hospital Melbourne VIC Australia

4. Johns Hopkins University School of Medicine Baltimore MD

5. Cliniques Universitaires St LucUniversité Catholique de Louvain Brussels Belgium

6. First Affiliated Hospital of Kunming Medical College Kunming China

7. Eighth People’s Hospital of Guangzhou Guangzhou China

8. LLC Medical Company ‘Hepatolog’ Samara Russian Federation

9. SouthWest HospitalThird Military Medical University Chongqing China

10. Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou China

11. Roche (China) Holding Ltd Shanghai China

12. Roche Pharma Research and Early DevelopmentRoche Innovation Center Basel Switzerland

13. Roche Products Limited Welwyn Garden City United Kingdom

Funder

F. Hoffmann-La Roche Ltd

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30050

Reference50 articles.

1. World Health Organization (WHO).Hepatitis B Fact Sheet (reviewed July 2017).http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed January2018.

2. Acute Hepatitis B Virus Infection: Relation of Age to the Clinical Expression of Disease and Subsequent Development of the Carrier State

3. Hepatitis B Virus Infection

4. Management of Chronic Hepatitis B in Children

5. Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon stimulated immune profile changes in a humanized mouse model of HBV infection;Nature Communications;2023-11-15

2. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022);Journal of Clinical and Translational Hepatology;2023-08-15

3. Role of CXCR5⁺CD8⁺ T cells in human hepatitis B virus infection;Journal of Viral Hepatitis;2023-05-02

4. Hepatitis during childhood;Comprehensive Guide to Hepatitis Advances;2023

5. The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B;BMC Pediatrics;2022-07-20